Abstract
Nephropathic cystinosis is a severe, monogenic systemic disorder that presents early in life and leads to progressive organ damage, particularly affecting the kidneys. It is caused by mutations in the CTNS gene, which encodes the lysosomal transporter cystinosin, resulting in intralysosomal accumulation of cystine. Recent studies demonstrated that the loss of cystinosin is associated with disrupted autophagy dynamics, accumulation of distorted mitochondria, and increased oxidative stress, leading to abnormal proliferation and dysfunction of kidney cells. We discuss these molecular mechanisms driving nephropathic cystinosis. Further, we consider how unravelling molecular mechanisms supports the identification and development of new strategies for cystinosis by the use of small molecules, biologicals, and genetic rescue of the disease in vitro and in vivo.
Original language | English |
---|---|
Pages (from-to) | 673-686 |
Number of pages | 14 |
Journal | Trends in Molecular Medicine |
Volume | 27 |
Issue number | 7 |
Early online date | 8 May 2021 |
DOIs | |
Publication status | Published - 1 Jul 2021 |
Bibliographical note
Funding Information:This work was financially supported by a grant from the Dutch Kidney Foundation (grant nr. 150KG19 ).
Publisher Copyright:
© 2021 Elsevier Ltd
Keywords
- CTNS gene
- cystinosis
- lysosomal storage disorder
- renal Fanconi syndrome
- therapeutic strategies